For the quarter ending 2025-09-30, OLMA has $352,453K in assets. $44,965K in debts. $35,260K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 35,260 | 52,473 | ||
| Marketable securities | 293,700 | 309,440 | ||
| Prepaid expenses and other current assets | 5,369 | 5,812 | ||
| Total current assets | 334,329 | 367,725 | ||
| Operating lease right-of-use assets | 1,419 | 1,685 | ||
| Other assets and long-term deposits | 16,705 | 12,592 | ||
| Total assets | 352,453 | 382,002 | ||
| Accounts payable | 3,474 | 934 | ||
| Operating lease liabilities, current | 1,168 | 1,153 | ||
| Other current liabilities (note 6) | 37,013 | 31,077 | ||
| Total current liabilities | 41,655 | 33,164 | ||
| Operating lease liabilities, net of current portion | 310 | 602 | ||
| Long-term borrowing | 3,000 | 3,000 | ||
| Total liabilities | 44,965 | 36,766 | ||
| Common stock, 0.0001 par value 490,000,000 shares authorized as of september 30, 2025 and december 31, 2024 68,652,730 and 74,312,608 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 7 | 7 | ||
| Additional paid-in capital | 858,451 | 854,194 | ||
| Accumulated other comprehensive income | 526 | 314 | ||
| Accumulated deficit | -551,496 | -509,279 | ||
| Total stockholders' equity | 307,488 | 345,236 | ||
| Total liabilities and stockholders' equity | 352,453 | 382,002 | ||
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)